BridgeMD
Compares treatment options for Supraglottic Airway Devices Position
Official title New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway
ClinicalTrials.gov ID: NCT07177586
What this study is testing
- What it's testing
- This study aims to compare the new-generation GMA laryngeal mask airway (LMA) with the traditional inflatable LMA in patients undergoing elective surgery under general anesthesia. The primary objectives are to evaluate the safety, effectiveness, stability, ease of use, and patient comfort of the GMA LMA, providing practical guidance for clinical airway management.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- 1. Age 18-75 years;
- ASA physical status I-II;
- Strict compliance with ASA fasting guidelines;
- Normal airway anatomy;
- Voluntary participation with signed informed consent.
You likely can't join if
- Pre-existing aspiration risk or gastrointestinal disorders;
- Oropharyngeal/laryngeal abnormalities;
- Anticipated difficult airway (≥1 of the following): BMI \>30 kg/m² Mouth opening \<3 cm Mallampati class III-IV Restricted neck mobility
- Contraindications to LMA use;
- Communication or cognitive impairments;
- Other exclusions at investigator's discretion
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.